NCT01680107View on ClinicalTrials.gov

D-cycloserine Augmented CBT for Panic Disorder

PHASE3TerminatedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

April 30, 2018

Conditions

Panic Disorder

Interventions

DRUG

d-cycloserine

DRUG

placebo

BEHAVIORAL

cognitive-behaviour therapy

Trial Locations (1)

OX37JX

Department of Psychiatry, University of Oxford, Oxford

Sponsors

Collaborators (1)

Medical Research Council

All Listed Sponsors

collaborator

Medical Research Council

OTHER_GOV

lead

University of Oxford

OTHER

NCT01680107 - D-cycloserine Augmented CBT for Panic Disorder | Biotech Hunter | Biotech Hunter